Clorox slides after disappointing results, downbeat sales forecast

Shares of Clorox CLX.N down 3.6% at $133.38, a nine-mth low, after cleaning product maker's fiscal Q3 results disappointed Wall Street and it cut 2025 sales outlook

Oakland, California-based Pine-Sol parent late Mon posted adj EPS of $1.45 on rev of $1.67 bln, shy of the $1.57 in earnings and $1.73 bln in rev anticipated by analysts, per LSEG

Co trimmed annual sales forecast as consumer demand weakens amid economic uncertainty spurred by U.S. President Donald Trump's tariffs

For fiscal 2025, it anticipates sales to be down 1% to flat, compared with its earlier target of down 1% to up 2%

At least 6 brokerages cut their PTs reacting to the news, including JP Morgan, BofA Global Research and Morgan Stanley

JP Morgan said it remains on the sidelines, pointing to expected pull forward benefit reversal in first half of fiscal 2026, continued high promotions in some categories

BofA said new PT of $145 (down from $150) fairly balances CLX's near-term volume recovery amid increasingly challenged consumer backdrop against improved margin trajectory post-cyberattack

Of 21 brokerages covering CLX, recommendation breakdown is 3 "strong buy" or "buy", 14 "hold" and 4 "sell"; median PT of $147 down from $165 a month ago - LSEG

With move on the session, stock down ~18% YTD vs S&P 500 Consumer Staples sector's .SPLRCS 5% advance